Etomidate: Difference between revisions
(Created page with "==RSI== 0.3 mg/kg bolus IV {Adult standard = 20mg) ==Procedural Sedation== 0.15 mg/kg bolus IV (Adult standard = 10mg) ==Source== Category:Meds") |
No edit summary |
||
(31 intermediate revisions by 9 users not shown) | |||
Line 1: | Line 1: | ||
== | ''See [[critical care quick reference]] for drug doses by weight.'' | ||
==General== | |||
*Type: [[Sedation|Sedative]] | |||
*Dosage Forms: | |||
*Common Trade Names: Amidate | |||
== | ==Adult Dosing== | ||
0. | ===[[RSI]]=== | ||
*0.3mg/kg bolus IV | |||
*Average: 20mg | |||
**Consider halving does for patients in [[shock]] | |||
== | ===[[Procedural Sedation]]=== | ||
{{Procedure sedation etomidate}} | |||
[[Category: | ==Pediatric Dosing== | ||
''See [[critical care quick reference]] for drug doses by weight.'' | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | |||
*Lactation: etomidate is present in breast milk | |||
*Renal Dosing | |||
**Adult | |||
*** Not defined however higher risk of toxicity with renal impairment | |||
**Pediatric | |||
*** Not defined however higher risk of toxicity with renal impairment | |||
*Hepatic Dosing | |||
**Adult | |||
*** Not defined | |||
**Pediatric | |||
*** Not defined | |||
==Contraindications== | |||
*Allergy to class/drug | |||
==Adverse Reactions== | |||
*Myoclonus | |||
*Nausea/Vomiting | |||
*Pain at injection site | |||
* apnea | |||
===Controversy=== | |||
"The available evidence suggests that etomidate suppresses adrenal function transiently without | |||
demonstrating a significant effect on mortality. However, no studies to date have been powered to detect a difference in hospital, ventilator, or ICU length of stay or in mortality."<ref>*Hohl CM, Kelly-Smith CH,Yeung TC, Sweet DD, Doyle-Waters MM, Schulzer M. The effect of a bolus dose of Etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med. 2010;56(2):105-113.</ref> | |||
==Pharmacology== | |||
*Half-life: 75 minutes | |||
*Metabolism: Liver | |||
*Excretion: Urine | |||
*Mechanism of Action: GABA agonist | |||
==See Also== | |||
==References== | |||
<references/> | |||
[[Category:Pharmacology]] | |||
[[Category:Critical Care]] | |||
Etomidate: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019. |
Latest revision as of 16:42, 13 May 2021
See critical care quick reference for drug doses by weight.
General
- Type: Sedative
- Dosage Forms:
- Common Trade Names: Amidate
Adult Dosing
RSI
- 0.3mg/kg bolus IV
- Average: 20mg
- Consider halving does for patients in shock
Procedural Sedation
- 0.1mg/kg one time dosing
- Max: 10mg
- Minimal respiratory depression but decrease blood pressure and heart rate (alpha2 agonism)
Pediatric Dosing
See critical care quick reference for drug doses by weight.
Special Populations
- Pregnancy Rating: C
- Lactation: etomidate is present in breast milk
- Renal Dosing
- Adult
- Not defined however higher risk of toxicity with renal impairment
- Pediatric
- Not defined however higher risk of toxicity with renal impairment
- Adult
- Hepatic Dosing
- Adult
- Not defined
- Pediatric
- Not defined
- Adult
Contraindications
- Allergy to class/drug
Adverse Reactions
- Myoclonus
- Nausea/Vomiting
- Pain at injection site
- apnea
Controversy
"The available evidence suggests that etomidate suppresses adrenal function transiently without demonstrating a significant effect on mortality. However, no studies to date have been powered to detect a difference in hospital, ventilator, or ICU length of stay or in mortality."[1]
Pharmacology
- Half-life: 75 minutes
- Metabolism: Liver
- Excretion: Urine
- Mechanism of Action: GABA agonist
See Also
References
- ↑ *Hohl CM, Kelly-Smith CH,Yeung TC, Sweet DD, Doyle-Waters MM, Schulzer M. The effect of a bolus dose of Etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med. 2010;56(2):105-113.
Etomidate: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.